Quality of Life in Patients With Inoperable Malignant Bowel Obstruction
- 05 September 2024 - 1 mins read
The primary objective of the study is to evaluate the impact on quality of life of Lanreotide Autogel 120 mg in combination with standard care, in comparison to the standard care alone, in subjects affected by inoperable malignant bowel obstruction.
05 September 2024
1 mins read
Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly
05 September 2024
1 mins read
Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg
05 September 2024
1 mins read
Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients
05 September 2024
1 mins read
Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.
05 September 2024
1 mins read
Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in Patients With Primary Myofascial Pain Syndrome
05 September 2024
1 mins read
Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours
05 September 2024
1 mins read
Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment
05 September 2024
1 mins read
Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer
05 September 2024
1 mins read
Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction
05 September 2024
1 mins read